Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Tanya Baron"'
Autor:
J Melhorn, Samer Elkhodair, Ruth Knight, Phil Moss, Jonathan Underwood, A Wang, Vicki S Barber, M Jabeen, Susan J Dutton, Tanya Baron, Lucy Cureton, Daniel Lasserson, Sophie B. Morgan, Jennifer L Cane, David Clarke, Duncan Richards, Rajendar Garlapati, Hinks Tsc., Ian D. Pavord, Joanna Black, Fleur Cantle, Graham Johnson
Publikováno v:
Developing treatments for COVID-19.
Background The antibacterial, anti-inflammatory and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease are lacking. We assessed whether azithromycin is effective in reducing h
Autor:
Ruth Knight, Jonathan Underwood, Joanna Black, Maisha Jabeen, Fleur Cantle, Susan J Dutton, Timothy S. C. Hinks, James F. Melhorn, Phil Moss, Ariel Wang, Sophie B. Morgan, Duncan Richards, Jennifer L Cane, Graham Johnson, Vicki S Barber, David Clarke, Rajendar Garlapati, Samer Elkhodair, Ian D. Pavord, Lucy Cureton, Daniel Lasserson, Tanya Baron
Publikováno v:
The Lancet. Respiratory Medicine
Background The antibacterial, anti-inflammatory, and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-to-moderate disease are not available. We assessed whether azithromycin is effective in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2e7944cd3467f2477596b13badde5575
Autor:
Lucy Cureton, Daniel Lasserson, Duncan Richards, Tanya Baron, Ian D. Pavord, Jonathan Underwood, Jennifer L Cane, Graham Johnson, David Clarke, Joanna Black, Fleur Cantle, Ruth Knight, Timothy S. C. Hinks, Sophie B. Morgan, Ariel Wang, Phil Moss, Susan J. Dutton, Samer Elkhodair, Rajendar Garlapati, James F. Melhorn, Maisha Jabeen, Vicki S Barber
BackgroundThe antibacterial, anti-inflammatory and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease are lacking. We assessed whether azithromycin is effective in reducing ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd515e3c90eba5af49fcb4d884ddd68d
https://doi.org/10.1101/2021.04.21.21255807
https://doi.org/10.1101/2021.04.21.21255807
Autor:
Samer Elkhodair, Jonathan Underwood, Vicki S Barber, Phil Moss, Tanya Baron, Lucy Cureton, Ian D. Pavord, Maisha Jabeen, Susan J. Dutton, Daniel Lasserson, Rajendar Garlapati, Joanna Black, Graham Johnson, Fleur Cantle, Sophie B. Morgan, Jennifer L Cane, Ruth Knight, David Clarke, Duncan Richards, Timothy S. C. Hinks, James F. Melhorn, Ariel Wang
Publikováno v:
SSRN Electronic Journal.
Background: The antibacterial, anti-inflammatory and antiviral properties of azithromycin suggest therapeutic potential against COVID-19. Randomised data in mild-moderate disease are lacking. We assessed whether azithromycin is effective in reducing
Autor:
Tanya Baron, Alex Novak
Publikováno v:
BMJ evidence-based medicine. 26(6)
The incidence of traumatic brain injury (TBI) is rising, with over 60 million people affected annually across the globe. 1 Tranexamic acid (TXA) is an inhibitor of fibrinolysis, which is readily available, easily administered, can be given in the pre